Witfire Elite · Clinical Catalysts · Trial Design Audit Pulnovo says two U.S. participants have undergone PULSE-LHD procedures at Henry Ford. The registry estimates total enrolment at 750, including ...
The ravulizumab ARTEMIS trial has been terminated at 555 patients. Read alone it is one failed study. Read against the registry it is the sixth attempt to take a rare-disease drug into a large ...
OX40 atopic dermatitis development ended this month. Sanofi said on 24 July it will not file amlitelimab, four months after Kyowa Kirin halted every rocatinlimab trial on safety grounds. Both ...
Witfire Elite · Clinical Catalysts · Registry Analysis The ravulizumab ARTEMIS trial has been terminated at 555 patients. Read alone it is one failed… ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results